Arrivent Biopharma, Inc.
Arrivent Biopharma, Inc. is a Private limited company (Ltd.) registered in United States under 3614334, and its current status with Pennsylvania Department of State is active. The company was incorporated on 9 January 2023 and lists its registered address as United States. 5 shareholders are on record for Arrivent Biopharma, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Pennsylvania Department of State and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Arrivent Biopharma, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 5.4% — the largest recorded stake — followed by Infinitum Asset Management, LLC at 5.4%; the remaining 3 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 5.4% | Pennsylvania Department of State | |
| Infinitum Asset Management, LLC | 5.4% | Pennsylvania Department of State | |
| Infinitum Asset Management, LLC | 4.3% | Pennsylvania Department of State | |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.4% | Pennsylvania Department of State | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.7% | Pennsylvania Department of State |
Officers
5
The Co-founder, Chairman, President & Ceo of Arrivent Biopharma, Inc. currently on record is Zhengbin Yao Ph.d.; five officers are currently on record for Arrivent Biopharma, Inc., filed with Pennsylvania Department of State.
The register reports 11 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Arrivent Biopharma, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Arrivent Biopharma, Inc.?
Five shareholders are currently on record for Arrivent Biopharma, Inc., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 5.4% — the largest recorded stake — followed by Infinitum Asset Management, LLC at 5.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Arrivent Biopharma, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Arrivent Biopharma, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Arrivent Biopharma, Inc. have on record?
5 shareholders are shown on record for Arrivent Biopharma, Inc..
What is Arrivent Biopharma, Inc.'s company registration number?
Arrivent Biopharma, Inc.'s registration number is 3614334, filed with Pennsylvania Department of State in United States. Its current status on the register is active.
Is Arrivent Biopharma, Inc. still an active company?
Arrivent Biopharma, Inc.'s status on Pennsylvania Department of State is listed as active.
When was Arrivent Biopharma, Inc. incorporated?
Arrivent Biopharma, Inc. was incorporated on 9 January 2023, according to Pennsylvania Department of State.
What is Arrivent Biopharma, Inc.'s registered address?
The registered address on file for Arrivent Biopharma, Inc. is United States.
What legal structure is Arrivent Biopharma, Inc. registered as?
Arrivent Biopharma, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of Arrivent Biopharma, Inc.?
The Co-founder, Chairman, President & Ceo of Arrivent Biopharma, Inc. currently on record is Zhengbin Yao Ph.d.; five officers are currently on record for Arrivent Biopharma, Inc., filed with Pennsylvania Department of State. Management authority at Arrivent Biopharma, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Arrivent Biopharma, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Pennsylvania Department of State. Zavia's monitoring API can track changes to Arrivent Biopharma, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Arrivent Biopharma, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Arrivent Biopharma, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Pennsylvania Department of State and was last synced on 21 October 2026.